Purpose To provide evidence-based recommendations to practicing oncologists, surgeons,
and radiation therapy clinicians to update the 2005 clinical practice guideline on the use of …

Purpose: To provide current recommendations on the use of sentinel node biopsy (SNB) for
patients with earlystage breast cancer. Methods: PubMed and the Cochrane Library were …

Purpose To evaluate the efficacy and safety of ixabepilone in patients with metastatic breast
cancer (MBC) resistant to anthracycline, taxane, and capecitabine, in this multicenter, phase …

… Bosserman, Cindy Geoghegan, Bruce E. Hillner, Richard L. Theriault, Dan S. …
Employment or Leadership: None Consultant or Advisory: Linda Bosserman, Amgen (C) …

Background Postmenopausal women with breast cancer receiving adjuvant aromatase
inhibitors (AIs) are at risk for accelerated bone loss and subsequent fractures. The ongoing …

BACKGROUND: Postmenopausal breast cancer (BC) patients receiving adjuvant aromatase
inhibitor therapy are at risk of progressive bone loss and fractures. Zoledronic acid inhibits …

Purpose To update, in collaboration with Cancer Care Ontario (CCO), key recommendations
of the American Society of Clinical Oncology (ASCO) guideline on the role of bone-…

The high prices of cancer drugs are affecting the care of patients with cancer and our health
care system. 1 In the United States, the average price of new cancer drugs increased 5-to 10-…

Background Multiple recent reports have documented significant variability of reoperation
rates after initial lumpectomy for breast cancer. To address this issue, a multidisciplinary …

Background The frequency of aromatase inhibitor (AI)–associated arthralgia and/or bone
pain in clinical practice is not known. Patients and Methods Fifty-six consecutive patients with …